Turn Therapeutics Inc. Common Stock (TTRX)

Turn Therapeutics Inc. Common Stock (TTRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $337M; returns 1 day +1.0%, 1 week -2.7%, 1 year +107.7%.

Turn Therapeutics Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for dermatologic, infectious diseases, and advanced wound care.

Groups TTRX belongs to

• Biotechnology
• Clinical Stage Biotech
• Clinical Stage
• Dermatology
• Healthcare
• Immunotherapy
• Infectious Diseases
• R&D
• Life Sciences

TTRX financial model: income statement, cash flow and balance sheet